Champions Oncology, Inc. (CSBR) Stock Price & Analysis

Champions Oncology, Inc. (CSBR) fell 1.14% to USD 5.22 as of September 8, 2026 at 09:05 UTC, according to Nexqual real-time market data.

CSBR last closed at USD 5.22; the session ranged USD 5.08–5.41 on volume of 10,946 shares. Market capitalization is —, with a 52-week range of USD 4.83–8.74 (NCM). Source: Nexqual, September 8, 2026 at 09:05 UTC.

Key Statistics (as of September 8, 2026 at 09:05 UTC)

Technical Analysis (CSBR)

Nexqual's technical model rates CSBR "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 09:05 UTC.

From Champions Oncology, Inc.'s Latest SEC 10-K Filing (filed 2026-07-27)

Key Strengths & Strategy (as disclosed to the SEC)

• Software As A Service (SaaS) Business Our SaaS business is centered around our proprietary software platform and data tool, Lumin Bioinformatics ("Lumin"), which contains comprehensive information derived from our research services and clinical studies and is sold to customers on an annual subscription basis.
• The Datacenter combines our proprietary dataset with other large publicly available datasets.
• Drug Discovery and Developmen t: Our Drug Discovery and Development business places us in a good position of also competing against the same customers of our Research Services and/or SaaS businesses: the global biopharmaceutical industry.
• At the core of our research platforms is our unique, proprietary bank of Patient Derived Xenograft (PDX) models.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:05 UTC. This page is informational and not investment advice.